Showing results (171-180 of 219) with videos related to

Sort By:
Pageof 22
European Urology Oncology|May 31, 2022
First-line Systemic Treatment of Recurrent Prostate Cancer After Primary or Salvage Local Therapy: A Systematic Review of the LiteratureAdam B Weiner, Aisha L Siebert, Sarah E Fenton, et al.
European Radiology|June 27, 2020
Pre-treatment amide proton transfer imaging predicts treatment outcome in nasopharyngeal carcinomaSahrish Qamar, Ann D King, Qi-Yong H Ai, et al.
American Journal of Hematology|July 10, 2001
Therapeutic choices for patients with hemophilia and high-titer inhibitorsR Kulkarni, L M Aledort, E Berntorp, et al.
Bone Marrow Transplantation|May 1, 1997
Partially mismatched blood cell transplants for high-risk hematologic malignancyJ A Russell, S Desai, B Herbut, et al.
Journal of Thrombosis and Haemostasis : JTH|May 19, 2006
Tailored prophylaxis in severe hemophilia A: interim results from the first 5 years of the Canadian Hemophilia Primary Prophylaxis StudyB M Feldman, M Pai, G E Rivard, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 28, 2017
A prospective study of health-related quality of life of boys with severe haemophilia A in China: comparing on-demand to prophylaxis treatmentR Wu, J Sun, J Xiao, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|December 1, 2017
Nasopharyngeal carcinoma: relationship between invasion of the prevertebral space and distant metastasesQi-Yong Ai, Chen-Wen Hu, Kunwar S Bhatia, et al.
Science (New York, N.Y.)|September 9, 1983
Antibodies to human T-cell leukemia virus membrane antigens (HTLV-MA) in hemophiliacsM Essex, M F McLane, T H Lee, et al.
Pageof 22